- Patent Title: 5-membered heteroaryl carboxamide compounds for treatment of HBV
-
Application No.: US17989237Application Date: 2022-11-17
-
Publication No.: US12030869B2Publication Date: 2024-07-09
- Inventor: Simon Nicolas Haydar , Leping Li , Mark G. Bures , Roopa Rai , Lynne Bannen , Michael Walker
- Applicant: Assembly Biosciences, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: ASSEMBLY BIOSCIENCES, INC.
- Current Assignee: ASSEMBLY BIOSCIENCES, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Barnes & Thornburg LLP
- Main IPC: C07D231/38
- IPC: C07D231/38 ; A61P31/20 ; C07D401/08 ; C07D403/04 ; C07D403/08 ; C07D403/10 ; C07D403/12 ; C07D405/04 ; C07D413/04 ; C07D413/08 ; C07D417/08
Abstract:
The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Public/Granted literature
- US20240150324A1 5-Membered Heteroaryl Carboxamide Compounds for Treatment of HBV Public/Granted day:2024-05-09
Information query
